Type: Whole-virion, inactivated SARS-CoV-2 vaccine manufactured using a Vero Cell manufacturing platform and inactivated with alum as adjuvant 2021 Status: EUA REQUEST TO FDA—Ocugen said November 5 ...

Bharat Biotech has signed a technology transfer agreement with Spain's Biofabri to enable end-to-end manufacturing of MTBVAC, ...

It turns out a COVID-19 vaccine that stirred controversy in India may be effective after all. The Indian government approved the use of the COVAXIN vaccine, made by the Indian company Bharat Biotech, ...

Hyderabad: Biofabri, a global human vaccine development company that is part of the Zendal group, and Bharat Biotech ...

Bharat Biotech partners with Biofabri to produce the MTBVAC tuberculosis vaccine, ensuring supply for over 70 countries.

NEW DELHI, Feb 9 (Reuters) - India's Bharat Biotech said on Tuesday it was likely to export its COVID-19 vaccine to Brazil and the United Arab Emirates this week, a major success for the shot approved ...

Biofabri and Bharat Biotech have entered a crucial technology transfer agreement to globally distribute MTBVAC, a tuberculosis vaccine. The partnership supports manufacturing in over 70 African and ...

MADISON, Wis.--(BUSINESS WIRE)--An international collaboration of virologists at the University of Wisconsin–Madison and the vaccine companies FluGen and Bharat Biotech has begun the development and ...

HYDERABAD (Reuters) - India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid ...

Chasing two U.S.-developed vaccine candidates, India’s Bharat Biotech says it’s ready to start testing its Zika shot in humans. It just needs the go-ahead from Indian officials to get started, ...

Despite a desperate need for Covid-19 vaccines, Brazil is suspending a deal to purchase 20 million doses of the Indian-made Covaxin vaccines, the Ministry of Health announced on Tuesday, after ...